Participants:18–64 years · 65+ years
Substances:N-{(2S,3R)-4,4-Difluoro-1-(2-Hydroxy-2-Methylpropanoyl)-2-[(2,3',5'-Trifluoro[1,1'-Biphenyl]-3-Yl)Methyl]Pyrrolidin-3-Yl}Ethanesulfonamide

Contact Research Centre

Sjogren's syndrome

Recruiting

Investigational

Study on the Effectiveness and Safety of Deucravacitinib for Adults with Active Sjogren's Syndrome

Investigational

France

Participants:18–64 years · 65+ years
Substances:Deucravacitinib

Contact Research Centre

Neoplasm malignant

Recruiting

Registered drugNo placebo

Study on the Long-term Safety and Efficacy of Pembrolizumab and Lenvatinib for Patients with Advanced Tumors

Registered drugNo placebo

France

Participants:18–64 years · 65+ years
Substances:Favezelimab

Contact Research Centre

Transitional cell carcinoma

Recruiting

Registered drugNo placebo

Adjuvant Datopotamab Deruxtecan with Drug Combination in Patients with High‑Risk Muscle‑Invasive Urothelial Carcinoma

Registered drugNo placebo

France

Participants:18–64 years
Substances:Durvalumab

Contact Research Centre

Gastrointestinal stromal tumour

Recruiting

InvestigationalNo placebo

Phase 3 Study of GSK6042981 versus Imatinib in Adults with Previously Untreated Metastatic or Unresectable Gastrointestinal Stromal Tumors (GIST)

InvestigationalNo placebo

France

Participants:18–64 years · 65+ years
Substances:Imatinib Mesilate

Contact Research Centre

Systemic scleroderma

Recruiting

Investigational

A double‑blind, placebo‑controlled trial of oral BI 1015550 in patients with systemic sclerosis

Investigational

France

Participants:18–64 years · 65+ years
Substances:Bi 1015550

Contact Research Centre

Hormone receptor positive HER2 negative breast cancer

Recruiting

Registered drugNo placebo

Study of BGB-43395 with letrozole versus CDK4/6 inhibitor drug combination with letrozole in patients with untreated advanced HR‑positive HER2‑negative breast cancer

Registered drugNo placebo

France

Participants:18–64 years · 65+ years
Substances:Abemaciclib

Contact Research Centre

HIV infection

Recruiting

Registered drugNo placebo

Switching to Lenacapavir, Teropavimab, and Zinlirvimab in Virologically Suppressed Adults with HIV-1: A Phase 3 Randomized Study

Registered drugNo placebo

France

Participants:18–64 years · 65+ years
Substances:Abacavir

Contact Research Centre

Huntington's disease

Recruiting

Investigational

Efficacy and safety of votoplam in adults with Huntington’s disease: a randomized, double‑blind, placebo‑controlled Phase 3 trial

Investigational

France

Participants:18–64 years · 65+ years
Substances:VOTOPLAM

Contact Research Centre

Pancreatic carcinoma metastatic

Recruiting

Registered drugNo placebo

Comparing Daraxonrasib Alone or Combined with Gemcitabine and Paclitaxel Albumin‑Bound vs Standard Chemotherapy in Patients with Metastatic Pancreatic Adenocarcinoma

Registered drugNo placebo

France

Participants:18–64 years · 65+ years
Substances:Gemcitabine

Contact Research Centre

Find therapies in clinical trials near you – page 3

1 156 trials match your criteria

Chronic kidney disease+1

Study on the Effects of Baxdrostat and Dapagliflozin in Adults with Chronic Kidney Disease and High Blood Pressure

Bladder transitional cell carcinoma

Study of Nadofaragene Firadenovec for Adults with Intermediate Risk Non-Muscle Invasive Bladder Cancer

Narcolepsy

Study on the Long-term Safety of TAK-861 for Patients with Narcolepsy Type 1

Sjogren's syndrome

Study on the Effectiveness and Safety of Deucravacitinib for Adults with Active Sjogren's Syndrome

Neoplasm malignant

Study on the Long-term Safety and Efficacy of Pembrolizumab and Lenvatinib for Patients with Advanced Tumors

Transitional cell carcinoma

Adjuvant Datopotamab Deruxtecan with Drug Combination in Patients with High‑Risk Muscle‑Invasive Urothelial Carcinoma

Gastrointestinal stromal tumour

Phase 3 Study of GSK6042981 versus Imatinib in Adults with Previously Untreated Metastatic or Unresectable Gastrointestinal Stromal Tumors (GIST)

Systemic scleroderma

A double‑blind, placebo‑controlled trial of oral BI 1015550 in patients with systemic sclerosis

Hormone receptor positive HER2 negative breast cancer

Study of BGB-43395 with letrozole versus CDK4/6 inhibitor drug combination with letrozole in patients with untreated advanced HR‑positive HER2‑negative breast cancer

HIV infection

Switching to Lenacapavir, Teropavimab, and Zinlirvimab in Virologically Suppressed Adults with HIV-1: A Phase 3 Randomized Study

Huntington's disease

Efficacy and safety of votoplam in adults with Huntington’s disease: a randomized, double‑blind, placebo‑controlled Phase 3 trial

Pancreatic carcinoma metastatic

Comparing Daraxonrasib Alone or Combined with Gemcitabine and Paclitaxel Albumin‑Bound vs Standard Chemotherapy in Patients with Metastatic Pancreatic Adenocarcinoma

Explore other searches

Vaccine trials

Paediatric trials · ages 0–17

Healthy volunteers

Helpful resources

How applying through us works

What happens after you apply

Guides for patients and volunteers

Search filters

Prefer not to search? Our Concierge searches the trials for you.